You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Oct 27, 2025

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
Published on: February 23, 2024
Xintao Qiu1, Avery S Feit2, Ariel Feiglin3
1Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
We developed CoBRA, a containerized workflow for reproducible Chromatin Immunoprecipitation sequencing (ChIP-seq) and Assay for Transposase-Accessible Chromatin (ATAC-seq) analysis. This pipeline simplifies complex genomic data analysis for researchers.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: